Applied Therapeutics, Inc. 2UV.F Stock
Applied Therapeutics, Inc. Price Chart
Applied Therapeutics, Inc. 2UV.F Financial and Trading Overview
| Applied Therapeutics, Inc. stock price | 4.92 EUR |
| Previous Close | 1.3 EUR |
| Open | 1.28 EUR |
| Bid | 1.28 EUR x N/A |
| Ask | 1.33 EUR x N/A |
| Day's Range | 1.28 - 1.28 EUR |
| 52 Week Range | 0.64 - 12 EUR |
| Volume | 100 EUR |
| Avg. Volume | 41 EUR |
| Market Cap | 74.33M EUR |
| Beta (5Y Monthly) | 1.901873 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.32 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 42.83 EUR |
2UV.F Valuation Measures
| Enterprise Value | 52.95M EUR |
| Trailing P/E | N/A |
| Forward P/E | -0.2981395 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 6.9724565 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 4.967 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Applied Therapeutics, Inc. Stock Price History
| Beta (5Y Monthly) | 1.901873 |
| 52-Week Change | -89.033% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 12 EUR |
| 52 Week Low | 0.64 EUR |
| 50-Day Moving Average | 1.15 EUR |
| 200-Day Moving Average | 0.98 EUR |
2UV.F Share Statistics
| Avg. Volume (3 month) | 41 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 57.85M |
| Float | 30.68M |
| Short Ratio | N/A |
| % Held by Insiders | 12.06% |
| % Held by Institutions | 66.18% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -663.29% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -93.078% |
| Return on Equity (ttm) | -366.96% |
Income Statement
| Revenue (ttm) | 10.66M EUR |
| Revenue Per Share (ttm) | 0.24 EUR |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -69524000 EUR |
| Diluted EPS (ttm) | -1.35 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 22.92M EUR |
| Total Cash Per Share (mrq) | 0.4 EUR |
| Total Debt (mrq) | 774K EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.874 |
| Book Value Per Share (mrq) | -0.085 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -60673000 EUR |
| Levered Free Cash Flow (ttm) | -21831876 EUR |
Profile of Applied Therapeutics, Inc.
| Country | Germany |
| State | NY |
| City | New York |
| Address | 545 5th Avenue |
| ZIP | 10017 |
| Phone | 212 220 9226 |
| Website | https://www.appliedtherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 26 |
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target central nervous system rare disease and diabetic complications in the United States. Its lead product candidate is AT-007 that has completed phase III for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.
Q&A For Applied Therapeutics, Inc. Stock
What is a current 2UV.F stock price?
Applied Therapeutics, Inc. 2UV.F stock price today per share is 4.92 EUR.
How to purchase Applied Therapeutics, Inc. stock?
You can buy 2UV.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Applied Therapeutics, Inc.?
The stock symbol or ticker of Applied Therapeutics, Inc. is 2UV.F.
Which industry does the Applied Therapeutics, Inc. company belong to?
The Applied Therapeutics, Inc. industry is Biotechnology.
How many shares does Applied Therapeutics, Inc. have in circulation?
The max supply of Applied Therapeutics, Inc. shares is 105.89M.
What is Applied Therapeutics, Inc. Price to Earnings Ratio (PE Ratio)?
Applied Therapeutics, Inc. PE Ratio is now.
What was Applied Therapeutics, Inc. earnings per share over the trailing 12 months (TTM)?
Applied Therapeutics, Inc. EPS is -1.32 EUR over the trailing 12 months.
Which sector does the Applied Therapeutics, Inc. company belong to?
The Applied Therapeutics, Inc. sector is Healthcare.